M Wierdak1, M Pisarska-Adamczyk1, M Wysocki2, P Major1, K Kołodziejska1, M Nowakowski1, T Vongsurbchart1, M Pędziwiatr1. 1. 2nd Department of General Surgery, Jagiellonian University Medical College, Jakubowskiego 2 Str., 30-688, Krakow, Poland. 2. 2nd Department of General Surgery, Jagiellonian University Medical College, Jakubowskiego 2 Str., 30-688, Krakow, Poland. m.wysocki@doctoral.uj.edu.pl.
Abstract
BACKGROUND: The aim of this study was to assess the usefulness of protective negative-pressure wound therapy (NPWT) in the reduction of wound healing complications (WHC) and surgical site infections (SSI) after diverting ileostomy closure in patients who underwent surgery for colorectal cancer. METHODS: In this prospective randomized clinical trial in a tertiary academic surgical center, patients who had colorectal cancer surgery with protective loop ileostomy and were scheduled to undergo ileostomy closure with primary wound closure from January 2016 to December 2018 were randomized to be treated with or without NPWT. The primary endpoint was the incidence of WHC. Secondary endpoints were incidence of SSI, length of postoperative hospital stay (LOS), and length of complete wound healing (CWH) time. RESULTS:We enrolled 35 patients NPWT (24 males [68.6%]; mean age 61.6 ± 11.3 years), with NPWT and 36 patients (20 males [55.6%]; mean age 62.4 ± 11.3 years) with only primary wound closure (control group). WHC was observed in 11 patients (30.6%) in the control group and 3 (8.57%) in the NPWT group (p = 0.020). Patients in the NPWT group had a significantly lower incidence of SSI (2 [5.71%] vs. 8 [22.2%] in the control group; p = 0.046) as well as significantly shorter median CWH (7 [7-7] days vs. 7 [7-15.5] days, p = 0.030). There was no difference in median LOS between groups (3 [2.5-5] days in the control group vs. 4 [2-4] days in the NPWT group; p = 0.072). CONCLUSIONS:Prophylactic postoperative NPWT after diverting ileostomy closure in colorectal cancer patients reduces the incidence of WRC and SSI. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov (NCT04088162).
RCT Entities:
BACKGROUND: The aim of this study was to assess the usefulness of protective negative-pressure wound therapy (NPWT) in the reduction of wound healing complications (WHC) and surgical site infections (SSI) after diverting ileostomy closure in patients who underwent surgery for colorectal cancer. METHODS: In this prospective randomized clinical trial in a tertiary academic surgical center, patients who had colorectal cancer surgery with protective loop ileostomy and were scheduled to undergo ileostomy closure with primary wound closure from January 2016 to December 2018 were randomized to be treated with or without NPWT. The primary endpoint was the incidence of WHC. Secondary endpoints were incidence of SSI, length of postoperative hospital stay (LOS), and length of complete wound healing (CWH) time. RESULTS: We enrolled 35 patients NPWT (24 males [68.6%]; mean age 61.6 ± 11.3 years), with NPWT and 36 patients (20 males [55.6%]; mean age 62.4 ± 11.3 years) with only primary wound closure (control group). WHC was observed in 11 patients (30.6%) in the control group and 3 (8.57%) in the NPWT group (p = 0.020). Patients in the NPWT group had a significantly lower incidence of SSI (2 [5.71%] vs. 8 [22.2%] in the control group; p = 0.046) as well as significantly shorter median CWH (7 [7-7] days vs. 7 [7-15.5] days, p = 0.030). There was no difference in median LOS between groups (3 [2.5-5] days in the control group vs. 4 [2-4] days in the NPWT group; p = 0.072). CONCLUSIONS: Prophylactic postoperative NPWT after diverting ileostomy closure in colorectal cancerpatients reduces the incidence of WRC and SSI. CLINICAL TRIAL REGISTRATION: clinicaltrials.gov (NCT04088162).
Entities:
Keywords:
Colorectal cancer operation; Ileostomy closure; Prevention of wound-related complications; Prophylactic negative pressure wound therapy; Randomized controlled trial
Authors: Michał Pędziwiatr; Mikhail Kisialeuski; Mateusz Wierdak; Maciej Stanek; Michał Natkaniec; Maciej Matłok; Piotr Major; Piotr Małczak; Andrzej Budzyński Journal: Int J Surg Date: 2015-07-29 Impact factor: 6.071
Authors: Donal Peter O'Leary; Colin Peirce; Breffini Anglim; Michael Burton; Elizabeth Concannon; Marguerite Carter; Kevin Hickey; John Calvin Coffey Journal: Ann Surg Date: 2017-06 Impact factor: 12.969
Authors: Wernard A A Borstlap; Emma Westerduin; Tjeerd S Aukema; Willem A Bemelman; Pieter J Tanis Journal: Ann Surg Date: 2017-11 Impact factor: 12.969
Authors: Stanisław Kłęk; Magdalena Pisarska; Katarzyna Milian-Ciesielska; Tomasz Cegielny; Ryszard Choruz; Jerzy Sałówka; Piotr Szybinski; Michał Pędziwiatr Journal: Wideochir Inne Tech Maloinwazyjne Date: 2018-11-13 Impact factor: 1.195
Authors: Gill Norman; Chunhu Shi; En Lin Goh; Elizabeth Ma Murphy; Adam Reid; Laura Chiverton; Monica Stankiewicz; Jo C Dumville Journal: Cochrane Database Syst Rev Date: 2022-04-26
Authors: Ernest Z Low; Timothy S Nugent; Niall J O'Sullivan; Dara Kavanagh; John O Larkin; Paul H McCormick; Brian J Mehigan; Michael E Kelly Journal: Int J Colorectal Dis Date: 2022-04-29 Impact factor: 2.796
Authors: Maciej Borejsza-Wysocki; Adam Bobkiewicz; Wojciech Francuzik; Lukasz Krokowicz; Dominik Walczak; Jacek Szmeja; Tomasz Banasiewicz Journal: Wideochir Inne Tech Maloinwazyjne Date: 2021-05-25 Impact factor: 1.195